CIDP IMPROVEMENTS FIVE YEARS
Chronic Inflammatory
Demyelinating Polyneuropathy (CIDP)
A rare neurological disorder. Targets your body's nerves all of which interact with the muscles within the body. Symptoms vary widely among individuals. Characterized by progressive weakness and impaired sensory function in both legs, feet, arms and hands. Weakened respiratory muscles are a common symptom.
CIDP prevalence is approximately 600 people in any one year in Australia of a population of 25 million.
Not hereditary nor infectious. Not a psychiatric or nervous disorder. Causes inflammation of nerves and nerve damage primarily to the insulating myelin sheaths around nerve fibres. Classified as an autoimmune disease. The disease may occur at any age. No known causes of why the immune system attacks the nerves of otherwise healthy people. A positive diagnosis of CIDP is possible with evidence of damage to peripheral nerve myelin from nerve conduction tests and a lumber puncture. Quadriplegia and or respiratory failure causing death has been cited in rare instances. Gullain-Barre Syndrome (GBS) is regarded as the acute form of the condition.
Traveldriven
SMOKO IN THE BACKYARD
CIDP MOBILITY ASSISTS
NOT REQUIRED
TWO YEARS OF CIDP
(23 months from hospitalisation)
THREE YEARS OF CIDP
(37 months from diagnosis)
Four years living with CIDP & IVIG
Five years living with CIDP & IVIG
Otherwise in good health,
no other issues
INFLAMMATORY NEUROPATHY
SUPPORT GROUP of VICTORIA
Melbourne Christmas Luncheon 2023
LUNCHEON FUND RAISING AUCTION
DJANGO REINHARDT
TWO FINGER GUITARIST
LEFT HANDED GUITARIST
TONY LOMMI
NEXT PAGE CIDP WRITTEN STORY
